| Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene. | lung, |
| cloning and functional analyses of the t(11;19) fusion oncogene: t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. | None |
| Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. | None |
| Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. | None |
| Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. | None |
| t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma. | None |